Covered recipient · General Payments record
JOHN THOMAS PAULSEL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,618.43
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.24 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $141.11 | 6 |
| Novo Nordisk AS | $54.48 | 2 |
| Acerta Pharma LLC | $29.69 | 2 |
| Radius Health, Inc. | $21.94 | 1 |
| Lilly USA, LLC | $18.27 | 1 |
| GlaxoSmithKline, LLC. | $18.02 | 1 |
| Kowa Pharmaceuticals America, Inc. | $14.10 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $13.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.32 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105215744 | CMS |
| ABBVIE INC. | $18.32 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105215748 | CMS |
| ABBVIE INC. | $21.91 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105215752 | CMS |
| ABBVIE INC. | $21.48 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105215756 | CMS |
| ABBVIE INC. | $34.02 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105215760 | CMS |
| ABBVIE INC. | $27.06 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105215764 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.48 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104439935 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.21 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104460872 | CMS |
| GlaxoSmithKline, LLC. | $18.02 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116377100 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.63 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146790975 | CMS |
| Kowa Pharmaceuticals America, Inc. | $14.10 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113469353 | CMS |
| Lilly USA, LLC | $18.27 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135072433 | CMS |
| Novo Nordisk Inc | $23.47 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097526597 | CMS |
| Novo Nordisk Inc | $31.01 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097664664 | CMS |
| Radius Health, Inc. | $21.94 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089962037 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.